Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Investing Activities (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Cash from Investing Activities for 5 consecutive years, with -$45000.0 as the latest value for Q1 2021.

  • Quarterly Cash from Investing Activities fell 101.34% to -$45000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was -$45000.0 through Dec 2021, up 40.27% year-over-year, with the annual reading at -$3.0 million for FY2025, 23479.87% down from the prior year.
  • Cash from Investing Activities for Q1 2021 was -$45000.0 at ENDRA Life Sciences, up from -$64850.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $11867.0 in Q3 2020, with the low at -$100000.0 in Q3 2018.
  • Average Cash from Investing Activities over 5 years is -$30198.9, with a median of -$22350.0 recorded in 2020.
  • Peak annual rise in Cash from Investing Activities hit 69.07% in 2020, while the deepest fall reached 326.61% in 2020.
  • Over 5 years, Cash from Investing Activities stood at -$7862.0 in 2017, then crashed by 1171.94% to -$100000.0 in 2018, then surged by 61.64% to -$38357.0 in 2019, then plummeted by 69.07% to -$64850.0 in 2020, then skyrocketed by 30.61% to -$45000.0 in 2021.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$45000.0, -$64850.0, and $11867.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.